1. Australia Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Alterity Therapeutics Limited

Alterity Therapeutics Limited

ATH.AX
Alterity Therapeutics LimitedAU flagAustralian Securities Exchange
0.71
AUD
+0.04
- -
154.43MMarket Cap

Total Valuation

Alterity Therapeutics Limited carries a market capitalization of 154.43M, placing it among publicly traded companies globally. Its enterprise value stands at -40.50M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap154.43M
Enterprise Value-40.50M

Share Statistics

Alterity Therapeutics Limited currently has 182.55M shares outstanding.

Shares Outstanding182.55M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Financial Position

Alterity Therapeutics Limited maintains a current ratio of 12.98, meaning it holds 13.0x the short-term assets needed to cover near-term liabilities.

Current Ratio12.98
Quick Ratio12.62
Debt / Equity0.37
Debt / EBITDAN/A
Interest CoverageN/A

Stock Price Statistics

Alterity Therapeutics Limited's stock has gained approximately 57.77778% over the past 52 weeks. The 50-day moving average sits at 0.51, while the 200-day moving average is 0.46.

Beta (5Y)N/A
52-Week Price Change57.77778%
50-Day Moving Average0.51
200-Day Moving Average0.46
Average Volume (20 Days)N/A

Balance Sheet

Alterity Therapeutics Limited holds 40.66M in cash and equivalents against 155,457.00 in total debt, resulting in a net debt position of -33.16M. Total book value stands at 37.06M, with working capital of 42.34M providing operational flexibility.

Cash & Cash Equivalents40.66M
Total Debt155,457.00
Net Debt-33.16M
Equity (Book Value)37.06M
Book Value Per ShareN/A
Working Capital42.34M

Stock Splits

Alterity Therapeutics Limited's most recent stock split took place on June 12, 2026 with a 50:1 split ratio.

Last Split Date6/12/2026
Split Ratio50:1

Scores

Alterity Therapeutics Limited posts an Altman Z-Score of -5.77, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-5.77